Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel, NCCAM SEP C-10.
Date: March 8, 2001.
Time: 1:30 p.m. to 3:00 p.m.Start Printed Page 11300
Agenda: To review and evaluate grant applications.
Place: 6707 Democracy Boulevard, Building II, Room 106, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Lawrence R. Haller, National Center for Complementary and Alternative Medicine, National Institutes of Health, 31 Center Drive, Room 5B50, Bethesda, MD 20892-2182, (301) 402-9011, firstname.lastname@example.org.Start Signature
Dated: February 15, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-4442 Filed 2-22-01; 8:45 am]
BILLING CODE 4140-01-M